For: | Deac AL, Burz CC, Bocsan IC, Buzoianu AD. Fluoropyrimidine-induced cardiotoxicity. World J Clin Oncol 2020; 11(12): 1008-1017 [PMID: 33437663 DOI: 10.5306/wjco.v11.i12.1008] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v11/i12/1008.htm |
Number | Citing Articles |
1 |
Jiayan Huang, Jiaojiao Zhang, Chengtao Sun, Ruiwen Yang, Miaomiao Sheng, Jiangning Hu, Guoyin Kai, Bing Han. Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms. Journal of Ethnopharmacology 2024; 318: 117022 doi: 10.1016/j.jep.2023.117022
|
2 |
Bogdan V. Vîlceleanu, Oana C. Voinea, Cosmin Buzila, Diana M. Ciobanu, Liviu Stan, Silviu I. Dumitrescu. Cardiotoxicity of Chemotherapy in Lynch Syndrome – A Literature Review. Romanian Journal of Military Medicine 2023; 126: 3 doi: 10.55453/rjmm.2023.126.5.1
|
3 |
Yajie Lu, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Hong-Mei Zhang. Time for Paying Attention to Fluoropyrimidine-Associated Cardiotoxicity: A Meta-Analysis for Epidemiology Based on 60537 Subjects. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4106539
|
4 |
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina.
DPYD
Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?
. Pharmacogenomics 2023; 24(2): 93 doi: 10.2217/pgs-2022-0135
|
5 |
Mohsen Rajaeinejad, Peyvand Parhizkar-Roudsari, Mehran Khoshfetrat, Mohammad Hassan Kazemi-galougahi, Reza Mosaed, Rasta Arjmand, Seyed Abolfazl Mohsenizadeh, Babak Arjmand. Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment. Cardiovascular Toxicology 2024; 24(2): 184 doi: 10.1007/s12012-024-09834-9
|
6 |
泽馨 刘. Recent Progress in Electrochemical Detection toward Anticancer Drug Fluorouracil—Detection Performance Improved by Novel Electrode Material. Hans Journal of Biomedicine 2022; 12(04): 295 doi: 10.12677/HJBM.2022.124036
|
7 |
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, Carmen Miano, Francesca Sacchi, Mattia Lauriola, Gabriele D’Uva. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.847012
|
8 |
Yajie Lu, Shizhou Deng, Qiongyi Dou, Wei Pan, Qingqing Liu, Hongchen Ji, Xiaowen Wang, Hong-Mei Zhang. Treatment-Related Coronary Disorders of Fluoropyrimidine Administration: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.885699
|
9 |
Yajie Lu, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Yan Chen, Jingyue Yang, Hong-Mei Zhang. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals 2023; 16(4): 510 doi: 10.3390/ph16040510
|
10 |
Sarah Nevins, Callan D. McLoughlin, Alfredo Oliveros, Joshua B. Stein, Mohammad Abdur Rashid, Yannan Hou, Mi‐Hyeon Jang, Ki‐Bum Lee. Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors. Small 2023; doi: 10.1002/smll.202300744
|